Clinical Trials for Ovarian Cancer Stage IV

Find clinical trials for ovarian cancer stage iv. Discover research opportunities and treatment options in your area.

13 Active Trials Found

Showing 13 trials on this page

Page 1 of 1

Sequential CD146 and GPC3 CAR-T Cell Therapy in Advanced Ovarian Cancer

NCT ID: NCT07067255

This clinical trial is testing a new treatment approach for people with advanced ovarian cancer that has come back or not responded to standard treatments. The treatment uses special immune cells c...

Recruiting

Phase: PHASE1 Type: interventional Locations: Beijing, Beijing, China

A Combination Therapy Strategy to Prevent Anti-PD-1 Therapy Resistance in Metastatic Ovarian Cancer Patients

NCT ID: NCT05479045

This clinical trial is exploring a new combination therapy aimed at helping women with advanced ovarian cancer (stages III and IV) who have not responded to standard platinum-based treatments. The ...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Washington, District Of Columbia, United States, Washington, District Of Columbia, United States +1 more

Predicting Outcome of Cytoreduction in Advanced Ovarian Cancer

NCT ID: NCT06017557

The PREDAtOOR clinical trial is a study designed to improve treatment choices for women with advanced ovarian cancer, specifically those in Stage III and IV. Researchers want to use a special techn...

Recruiting

Phase: NA Type: interventional Locations: Roma, , Italy

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

NCT ID: NCT06290193

This clinical trial is researching a method called Acute Normovolemic Hemodilution (ANH) in patients with advanced ovarian cancer who are scheduled for surgery. The goal of the trial is to see if u...

Recruiting

Phase: PHASE2 Type: interventional Locations: New York, New York, United States, Middletown, New Jersey, United States +6 more

Exercise as a Preventive Agent to Combat Immobility in Patients With Ovarian or Endometrial Cancers Receiving Chemotherapy

NCT ID: NCT04997096

This clinical trial is exploring whether a 16-week exercise program can help women with ovarian or endometrial cancer who are undergoing chemotherapy. The program includes both aerobic exercises (l...

Recruiting

Phase: NA Type: interventional Locations: Boston, Massachusetts, United States

Microdevice In Ovarian, Fallopian Tube, And Peritoneal Cancer

NCT ID: NCT04701645

This clinical trial is exploring a new device called an implantable microdevice, which is designed to measure how well chemotherapy and other treatments are working directly within tumors in women ...

Recruiting

Phase: PHASE1 Type: interventional Locations: Boston, Massachusetts, United States, Boston, Massachusetts, United States

NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study

NCT ID: NCT06650709

The NEoadjuvant Olaparib Combination OvArian Cancer Targeted Study is a clinical trial designed to explore whether a combination of three treatments—olaparib, durvalumab, and bevacizumab—can help s...

Not yet recruiting

Phase: PHASE2 Type: interventional

Tart Cherry Juice as a Dietary Supplement for the Prevention of Paclitaxel-Induced Neuropathy

NCT ID: NCT06268665

This clinical trial is studying whether tart cherry juice can help prevent nerve damage (neuropathy) caused by a chemotherapy drug called paclitaxel, which is commonly used to treat breast and ovar...

Recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

Tumor Microenvironment in Ovarian Cancer

NCT ID: NCT06272240

This clinical trial is studying the tumor microenvironment in women with advanced ovarian cancer, specifically those with Stage III and Stage IV serous ovarian carcinoma. The researchers aim to cre...

Recruiting

Type: observational Locations: Udine, Ud, Italy

Oregovomab in Combination With Bevacizumab Plus Chemo in BRCA Wild Type Platinum Sensitive Recurrent Ovarian Cancer

NCT ID: NCT04938583

This clinical trial is studying a new treatment approach for women with advanced ovarian cancer that has come back after initial treatment. Researchers are looking at a combination of three medicat...

Recruiting

Phase: PHASE1 Type: interventional Locations: Seoul, , Korea, Republic Of, Daegu, , Korea, Republic Of +5 more

Dynamic Monitoring of ctDNA Predicts Recurrence of Advanced Ovarian Cancer After Primary Treatments

NCT ID: NCT06025045

This clinical trial is investigating a new way to monitor ovarian cancer in women who have undergone surgery. Specifically, it looks at a test called ctDNA, which can help detect tiny amounts of ca...

Recruiting

Type: observational Locations: Guangzhou, Guangdong, China

Prehabilitation in Gynaecological Cancer Patients

NCT ID: NCT04789694

The PHOCUS trial is studying how a program called "prehabilitation" can help women with gynecological cancers, like ovarian and endometrial cancer, prepare for surgery. Prehabilitation includes exe...

Recruiting

Phase: PHASE3 Type: interventional Locations: Prague, , Czechia

PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer

NCT ID: NCT05187208

The clinical trial titled "PARP Inhibitor Oral Maintenance in Low-Risk Ovarian Cancer" is studying a medication called niraparib to see how well it works as a maintenance therapy for women with low...

Not yet recruiting

Phase: PHASE4 Type: interventional

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions